FAM122A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
<1E-12 |
Normal-vs-Stage2 |
6.3004002015532E-10 |
Normal-vs-Stage3 |
4.06563671617732E-13 |
Normal-vs-Stage4 |
3.213800E-04 |
Stage1-vs-Stage2 |
3.124800E-01 |
Stage1-vs-Stage3 |
8.288200E-01 |
Stage1-vs-Stage4 |
8.269200E-01 |
Stage2-vs-Stage3 |
4.373800E-01 |
Stage2-vs-Stage4 |
4.160400E-01 |
Stage3-vs-Stage4 |
7.372400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
<1E-12 |
Normal-vs-AfricanAmerican |
2.1094237467878E-15 |
Normal-vs-Asian |
6.1895000236234E-09 |
Caucasian-vs-AfricanAmerican |
4.308200E-01 |
Caucasian-vs-Asian |
2.702400E-01 |
AfricanAmerican-vs-Asian |
1.590650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
2.85327317328665E-14 |
Male-vs-Female |
4.055700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.17523785042795E-14 |
Normal-vs-Extreme_Weight |
<1E-12 |
Normal-vs-Obese |
1.62525548574877E-12 |
Normal-vs-Extreme_Obese |
8.09790012823441E-10 |
Normal_Weight-vs-Extreme_Weight |
7.462400E-01 |
Normal_Weight-vs-Obese |
4.671400E-01 |
Normal_Weight-vs-Extreme_Obese |
8.650400E-01 |
Extreme_Weight-vs-Obese |
2.389600E-01 |
Extreme_Weight-vs-Extreme_Obese |
9.821400E-01 |
Obese-vs-Extreme_Obese |
5.164200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.53620005605148E-10 |
Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
1.08509867757789E-11 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.553600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.977000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.741800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.248300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.434590E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.181600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
<1E-12 |
Normal-VS-Type2 PRCC |
<1E-12 |
Normal-VS-KIRP CIMP |
1.07500000012806E-07 |
Normal-VS-Unclassified PRCC |
1.43310030509269E-10 |
Type1 PRCC-VS-Type2 PRCC |
4.550200E-01 |
Type1 PRCC-VS-KIRP CIMP |
9.090600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
3.845200E-01 |
Type2 PRCC-VS-KIRP CIMP |
6.559200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.865410E-01 |
KIRP CIMP-VS-Unclassified PRCC |
7.385200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
<1E-12 |
Normal-vs-N1 |
9.92840000213491E-08 |
Normal-vs-N2 |
1.25380000048914E-07 |
N0-vs-N1 |
1.844650E-01 |
N0-vs-N2 |
4.649200E-01 |
N1-vs-N2 |
2.793200E-01 |
|
|